Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T21:52:36.236Z.
Calculation as of: 2026-10-06T21:52:36.236Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
NOMAD Power Solutions, Inc.
Market Cap
$53.70M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $53.70M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | N/A |
| Aldeyra The (ALDX)vs › | $55.25M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A |
| ImageneBio Inc (IMA)vs › | $51.88M | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
